Novartis Psoriasis Drug Superior to Enbrel in StudyNovartis Psoriasis Drug Superior to Enbrel in Study

Novartis psoriasis drug secukinumab was superior to Amgen's Enbrel (etanercept) in a late-stage study. Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Dermatology News Source Type: news